Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.177.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.258.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.225ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.2.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AV.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.309ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.105ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.258.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.307ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.171ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.57ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.67ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.279ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.67ENiu-ECACGTTAACAATATTGCAGC20402639126372R-18330.5China
B.1.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AD.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.201ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
W.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.2.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.20ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.2.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JC.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KE.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.8.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.30ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.56ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JD.1.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDTENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.21ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.2.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.617.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.109 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.4.2.2 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.4.2.3 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.4.8 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.617.1 (Kappa)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.4.3 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.46.5 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.4.1 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
P.1.16 (Gamma)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.10.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.4.5 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.34.1 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.4.2.1 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used